Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Aaron Bradley Waxman, M.D., Ph.D.

TitleAssociate Professor of Medicine
InstitutionBrigham and Women's Hospital
DepartmentMedicine
AddressBrigham and Womens Hospital
Pulmonary and Critical Care
75 Francis St
Boston MA 02115
Phone617/525-9733
Fax617/732-7421

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Nakahira K, Kyung SY, Rogers AJ, Gazourian L, Youn S, Massaro AF, Quintana C, Osorio JC, Wang Z, Zhao Y, Lawler LA, Christie JD, Meyer NJ, Causland FR, Waikar SS, Waxman AB, Chung RT, Bueno R, Rosas IO, Fredenburgh LE, Baron RM, Christiani DC, Hunninghake GM, Choi AM. Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation. PLoS Med. 2013 Dec; 10(12):e1001577.
    View in: PubMed
  2. Opotowsky AR, Santos M, Maron BA, Afilalo J, Waxman AB, Landzberg MJ, Forfia PR. Towards widespread noninvasive assessment of pulmonary vascular resistance in clinical practice. J Am Soc Echocardiogr. 2014 Jan; 27(1):108-9.
    View in: PubMed
  3. Maron BA, Waxman AB, Opotowsky AR, Gillies H, Blair C, Aghamohammadzadeh R, Loscalzo J, Leopold JA. Effectiveness of Spironolactone Plus Ambrisentan for Treatment of Pulmonary Arterial Hypertension (from the [ARIES] Study 1 and 2 Trials). Am J Cardiol. 2013 Sep 1; 112(5):720-5.
    View in: PubMed
  4. Opotowsky AR, Clair M, Afilalo J, Landzberg MJ, Waxman AB, Moko L, Maron BA, Vaidya A, Forfia PR. A simple echocardiographic method to estimate pulmonary vascular resistance. Am J Cardiol. 2013 Sep 15; 112(6):873-82.
    View in: PubMed
  5. Maron BA, Cockrill BA, Waxman AB, Systrom DM. The invasive cardiopulmonary exercise test. Circulation. 2013 Mar 12; 127(10):1157-64.
    View in: PubMed
  6. Waxman AB, Zamanian RT. Pulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapies. Am J Cardiol. 2013 Mar 4; 111(5 Suppl):1A-16A.
    View in: PubMed
  7. Esch JJ, Shah PB, Cockrill BA, Farber HW, Landzberg MJ, Mehra MR, Mullen MP, Opotowsky AR, Waxman AB, Lock JE, Marshall AC. Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension: Initial clinical experience. J Heart Lung Transplant. 2013 Apr; 32(4):381-7.
    View in: PubMed
  8. Waxman AB. Oral prostacyclin therapy for pulmonary arterial hypertension: another step forward. Circulation. 2013 Feb 5; 127(5):563-5.
    View in: PubMed
  9. Cockrill BA, Waxman AB. Phosphodiesterase-5 inhibitors. Handb Exp Pharmacol. 2013; 218:229-55.
    View in: PubMed
  10. Waxman A, Chen SY, Boulanger L, Watson JA, Golden G. Factors associated with adherence to phosphodiesterase type 5 inhibitors for the treatment of pulmonary arterial hypertension. J Med Econ. 2013; 16(2):298-306.
    View in: PubMed
  11. Maron BA, Opotowsky AR, Landzberg MJ, Loscalzo J, Waxman AB, Leopold JA. Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study. Eur J Heart Fail. 2013 Mar; 15(3):277-83.
    View in: PubMed
  12. Waxman AB. Exercise physiology and pulmonary arterial hypertension. Prog Cardiovasc Dis. 2012 Sep-Oct; 55(2):172-9.
    View in: PubMed
  13. Maron BA, Bhatt DL, Nykiel M, Kinlay S, Waxman AB. Protocol for vasoreactivity testing with epoprostenol in pulmonary hypertension. Crit Pathw Cardiol. 2012 Mar; 11(1):40-2.
    View in: PubMed
  14. Parikh VN, Jin RC, Rabello S, Gulbahce N, White K, Hale A, Cottrill KA, Shaik RS, Waxman AB, Zhang YY, Maron BA, Hartner JC, Fujiwara Y, Orkin SH, Haley KJ, Barabási AL, Loscalzo J, Chan SY. MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach. Circulation. 2012 Mar 27; 125(12):1520-32.
    View in: PubMed
  15. Waxman AB. Pulmonary hypertension in heart failure with preserved ejection fraction: a target for therapy? Circulation. 2011 Jul 12; 124(2):133-5.
    View in: PubMed
  16. Schlichting DE, Waxman AB, O'Brien LA, Wang T, Naum CC, Rubeiz GJ, Um SL, Williams M, Yan SC. Circulating endothelial and endothelial progenitor cells in patients with severe sepsis. Microvasc Res. 2011 Mar; 81(2):216-21.
    View in: PubMed
  17. Kolliputi N, Shaik RS, Waxman AB. The inflammasome mediates hyperoxia-induced alveolar cell permeability. J Immunol. 2010 May 15; 184(10):5819-26.
    View in: PubMed
  18. Thibault HB, Kurtz B, Raher MJ, Shaik RS, Waxman A, Derumeaux G, Halpern EF, Bloch KD, Scherrer-Crosbie M. Noninvasive assessment of murine pulmonary arterial pressure: validation and application to models of pulmonary hypertension. Circ Cardiovasc Imaging. 2010 Mar; 3(2):157-63.
    View in: PubMed
  19. Troy PJ, Waxman AB. Portopulmonary hypertension: challenges in diagnosis and management. Therap Adv Gastroenterol. 2009 Sep; 2(5):281-6.
    View in: PubMed
  20. Kolliputi N, Waxman AB. IL-6 cytoprotection in hyperoxic acute lung injury occurs via PI3K/Akt-mediated Bax phosphorylation. Am J Physiol Lung Cell Mol Physiol. 2009 Jul; 297(1):L6-16.
    View in: PubMed
  21. Waxman AB, Kolliputi N. IL-6 protects against hyperoxia-induced mitochondrial damage via Bcl-2-induced Bak interactions with mitofusins. Am J Respir Cell Mol Biol. 2009 Oct; 41(4):385-96.
    View in: PubMed
  22. Steiner MK, Syrkina OL, Kolliputi N, Mark EJ, Hales CA, Waxman AB. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res. 2009 Jan 30; 104(2):236-44, 28p following 244.
    View in: PubMed
  23. Lee PS, Patel SR, Christiani DC, Bajwa E, Stossel TP, Waxman AB. Plasma gelsolin depletion and circulating actin in sepsis: a pilot study. PLoS One. 2008; 3(11):e3712.
    View in: PubMed
  24. Tolle JJ, Waxman AB, Van Horn TL, Pappagianopoulos PP, Systrom DM. Exercise-induced pulmonary arterial hypertension. Circulation. 2008 Nov 18; 118(21):2183-9.
    View in: PubMed
  25. Waxman AB, Lawler L, Cornett G. Cicletanine for the treatment of pulmonary arterial hypertension. Arch Intern Med. 2008 Oct 27; 168(19):2164-6.
    View in: PubMed
  26. Robertson TE, Mann HJ, Hyzy R, Rogers A, Douglas I, Waxman AB, Weinert C, Alapat P, Guntupalli KK, Buchman TG. Multicenter implementation of a consensus-developed, evidence-based, spontaneous breathing trial protocol. Crit Care Med. 2008 Oct; 36(10):2753-62.
    View in: PubMed
  27. Kolliputi N, Waxman AB. IL-6 cytoprotection in hyperoxic acute lung injury occurs via suppressor of cytokine signaling-1-induced apoptosis signal-regulating kinase-1 degradation. Am J Respir Cell Mol Biol. 2009 Mar; 40(3):314-24.
    View in: PubMed
  28. Chetty A, Cao GJ, Manzo N, Nielsen HC, Waxman A. The role of IL-6 and IL-11 in hyperoxic injury in developing lung. Pediatr Pulmonol. 2008 Mar; 43(3):297-304.
    View in: PubMed
  29. Tolle J, Waxman A, Systrom D. Impaired systemic oxygen extraction at maximum exercise in pulmonary hypertension. Med Sci Sports Exerc. 2008 Jan; 40(1):3-8.
    View in: PubMed
  30. LaRaia AV, Waxman AB. Pulmonary arterial hypertension: evaluation and management. South Med J. 2007 Apr; 100(4):393-9.
    View in: PubMed
  31. Lee PS, Waxman AB, Cotich KL, Chung SW, Perrella MA, Stossel TP. Plasma gelsolin is a marker and therapeutic agent in animal sepsis. Crit Care Med. 2007 Mar; 35(3):849-55.
    View in: PubMed
  32. Waxman AB. A review of sitaxsentan sodium in patients with pulmonary arterial hypertension. Vasc Health Risk Manag. 2007; 3(1):151-7.
    View in: PubMed
  33. Steiner MK, Preston IR, Klinger JR, Criner GJ, Waxman AB, Farber HW, Hill NS. Conversion to bosentan from prostacyclin infusion therapy in pulmonary arterial hypertension: a pilot study. Chest. 2006 Nov; 130(5):1471-80.
    View in: PubMed
  34. Barker GF, Manzo ND, Cotich KL, Shone RK, Waxman AB. DNA damage induced by hyperoxia: quantitation and correlation with lung injury. Am J Respir Cell Mol Biol. 2006 Sep; 35(3):277-88.
    View in: PubMed
  35. Lee PS, Waxman A. The importance of differentiating gelsolin isoforms. Am J Respir Crit Care Med. 2006 Mar 15; 173(6):685; author reply 685.
    View in: PubMed
  36. Garcia-Carbonero R, Supko JG, Maki RG, Manola J, Ryan DP, Harmon D, Puchalski TA, Goss G, Seiden MV, Waxman A, Quigley MT, Lopez T, Sancho MA, Jimeno J, Guzman C, Demetri GD. Ecteinascidin-743 (ET-743) for chemotherapy-naive patients with advanced soft tissue sarcomas: multicenter phase II and pharmacokinetic study. J Clin Oncol. 2005 Aug 20; 23(24):5484-92.
    View in: PubMed
  37. Waxman AB, Ward N, Thompson T, Lilly CM, Lisbon A, Hill N, Nasraway SA, Heard S, Corwin H, Levy M. Roundtable debate: Controversies in the management of the septic patient--desperately seeking consensus. Crit Care. 2005 Feb; 9(1):E1.
    View in: PubMed
  38. Chetty A, Manzo N, Waxman AB, Nielsen HC. Modulation of IGF-binding protein-2 and -3 in hyperoxic injury in developing rat lung. Pediatr Res. 2005 Aug; 58(2):222-8.
    View in: PubMed
  39. He CH, Waxman AB, Lee CG, Link H, Rabach ME, Ma B, Chen Q, Zhu Z, Zhong M, Nakayama K, Nakayama KI, Homer R, Elias JA. Bcl-2-related protein A1 is an endogenous and cytokine-stimulated mediator of cytoprotection in hyperoxic acute lung injury. J Clin Invest. 2005 Apr; 115(4):1039-48.
    View in: PubMed
  40. He CH, Waxman AB, Lee CG, Zhu Z, Chen Q, Elias JA,. Activation In Vivo And In Vitro And TRAIL, Fas, FAS-L, Bid, Bim, BAK And PKC-8 Gene Expression In Vivo. American Journal of Respiratory and Critical Care Medicine in press. 2004.
  41. Barker GF, Manzo N, Salzman AL, Szabo C, Waxman AB,. Inhibition Prolongs Survival in Oxidant-Mediated Lung Injury. American Journal of respiratory and Critical Care Medicine in press. 2004.
  42. Boyce PD, Waxman AB. Pulmonary hypertension: work in progress. J Nucl Cardiol. 2003 Jul-Aug; 10(4):413-23.
    View in: PubMed
  43. Waxman AB, Shepard JA, Mark EJ. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-2003. A 73-year-old woman with pneumonia and progressive respiratory failure. N Engl J Med. 2003 May 8; 348(19):1902-12.
    View in: PubMed
  44. Waxman AB, Mahboubi K, Knickelbein RG, Mantell LL, Manzo N, Pober JS, Elias JA. Interleukin-11 and interleukin-6 protect cultured human endothelial cells from H2O2-induced cell death. Am J Respir Cell Mol Biol. 2003 Oct; 29(4):513-22.
    View in: PubMed
  45. Waxman AB,. Invited Commentary on "Tidal Volume Increases Do Not Affect Alveolar Mechanics in Normal Lung But Cause Alveolar Overdistension And Exacerbate Alveolar Instability After Surfactant Deactivation.". Journal Club of the Assembly on Critical Care of the American Thoracic Society. 2003; (February).
  46. He CH, Waxman AB, Ma B, Lee CG, Zhu Z, Wang X, Chen Q, Elias JA,. the Bc1-2-Related A1 Protein Is An Endogenous And Cytokine-Stimulated Mediator Of Cytoprotection In Hyperoxic Acute Lung Injury. American Journal of respiratory and Critical Care Medicine. 2003; 167(7):A428.
  47. Manzo ND, Waxman AB. Pathogenesis of Acute Lung Injury: Experimental Studies. Acute Respiratory Distress Syndrome, Editor Michael Matthay. 2003; 179(Chapter 6):115-146.
  48. Boyce P, Waxman AB,. Pulmonary Hypertension: Work in Progress. Journal of Nuclear Cardiology. 2003; 10(4):413-423.
  49. Papa J, Sasidhar M, Waxman AB,. Hemodynamic Impact of Mechanical Ventilation in ARDS. Clinical Pulmonary Medicine. 2003; 10(3):154-161.
  50. Waxman AB, Shepart JAO, Mark EJ, . Case Records of the Massachusetts General Hospital Case 14-2003-A 73 Year Old Woman with Pneumonia and Progressive Respiratory Failure. New England Journal of Medicine. 2003; 348:1902-12.
  51. Waxman AB,. Invited commentary on "Noninvasive Ventilation during Persistent Weaning Fauilure; A Randomized Controlled Trial.". Journal Club of the Assembly on Critical care of the American Thoracic Society. 2003.
  52. Waxman AB, Manzo N, Li W,. Ad-Bc1-2 Mediated Overexpression Protects From Hyperoxic Lung Injury. American Journal of Respiratory and Critical Care Medicine. 2003; 167(7):A165.
  53. Budhiraja R, Waxman AB,. Pulmonary Hypertension: Diagnosis and Management. Resident and Staff Physician. 2002; 48(9):12-20.
  54. He CH, Waxman AB, Ma B, Lee CG, Zhu Z, Wang X, Chen Q, Elias JA,. The Bcl-2-Related A1 Gene Is Regulated In Vivo And In Vitro. American Journal of respiratory and Critical Care Medicine. 2002; 165(4).
  55. Waxman AB,. Invited commentary on "Prevention of Ventilator-associated Pneumonia by Oral Decontamination. A Prospective, Randomized, Double blind, Placebo-controlled Study.". Journal Club of the Assembly on Critical Care of the American Thoracic Society. 2002; (September).
  56. Waxman AB,. Invited Commentary on "Oscillations and Noise, Inherent Instability of Pressure Support Ventilation?". Journal Club of the Assembly on Critical Care of the American Thoracic Society. 2002; (February).
  57. Waxman AB. Pulmonary function test abnormalities in pulmonary vascular disease and chronic heart failure. Clin Chest Med. 2001 Dec; 22(4):751-8.
    View in: PubMed
  58. Buse K, Waxman A. Public-private health partnerships: a strategy for WHO. Bull World Health Organ. 2001; 79(8):748-54.
    View in: PubMed
  59. Waxman AB,. Pulmonary Function Testing in Pulmonary Vascular Disease and Chronic Heart Disease. Clinics in Chest Medicine, Pulmonary Function Testing. 2001; 22(4):751-758.
  60. Seithi J, Waxman AB,. Cellular and Molecular Mechanisms of Lung Injury and Repair. Clinical Pulmonary Medicine. 2001; 8(4):214-225.
  61. McArdle JR, Mantell L, Waxman AB, Du Y, Radzano P, Elias JA,. Vascular Endothelial Cell Growth Factor (VEGF) Confers Cytoprotection on Endothelial Cells in Vitro. American Journal of Respiratory and critical Care Medicine. 2001; 163(5).
  62. Waxman AB, . Invited Commentary on "The comfort of breathing: A study with volunteers assessing the influence of various modes of assisted ventillation. Journal Club of the Assembly on Critical Care of American Thoracic Society. 2001; (January).
  63. Corne J, Chupp G, Lee CG, Homer RJ, Zhu Z, Chen Q, Ma B, Du Y, Roux F, McArdle J, Waxman AB, Elias JA. IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J Clin Invest. 2000 Sep; 106(6):783-91.
    View in: PubMed
  64. Ward NS, Waxman AB, Homer RJ, Mantell LL, Einarsson O, Du Y, Elias JA. Interleukin-6-induced protection in hyperoxic acute lung injury. Am J Respir Cell Mol Biol. 2000 May; 22(5):535-42.
    View in: PubMed
  65. Corne J, Waxman AB, Elias JA,. Cc-10 Interleukin-13 (IL-13) Transgenic Mice Exhibit Enhanced Protection From Hyperoxic Lung Injury. American Journal of Respiratory and Critical Care Medicine. 2000; 164(4).
  66. Corne J, Waxman AB, Elias JA,. Vascular Endothelial Growth Factor (VEGF) But NOt Keratinocyte Growth Factor (KGF) Is Upregulated in Cc-10IL-13 Transgenic Mice Exposed To Hyperoxia. American Journal of Respiratory and Critical Care Medicine. 2000; 161(4).
  67. Waxman AB, Reilly MA, Du Y, Elias JA,. Cc-10IL-11 and Cc-10-IL-6 Overexpression Transgenic Mice Are Protected From Oxidant Mediated Cell Death Via Divergent Anti-Death Pathways. American Journal of Respiratory and Critical Care Medicine. 2000; 161(4).
  68. Waxman AB, . Invited commentary on "Prospective randomized trial comparing pressure-controlled ventilation and volume-controlled ventilation in ARDS.". Journal Club of the Assembly on Critical Care of American Thoracic Society. 2000; (July).
  69. Waxman AB, Du Y, Elias JA. IL-11 Protects Endothelial Cells From Oxidant Medicated Cell Death. American Journal of Respiratory and Critical Care Medicine. 2000; 161(4).
  70. Ward NS, Waxman AB, Einarsson O, Elias JA. Interleukin-6 protection in hyperoxic lung injury. Chest. 1999 Jul; 116(1 Suppl):26S.
    View in: PubMed
  71. Waxman AB, Einarsson O, Seres T, Knickelbein RG, Homer R, Warshaw JB, Johnston R, Elias JA. Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. Chest. 1999 Jul; 116(1 Suppl):8S-9S.
    View in: PubMed
  72. Waxman AB, Sasidhar M,. Practical Use of the Pulmonary Artery Catheter in the ICU. Journal of Respiratory Diseases. 1999; 20(June):106-118.
  73. Ward NS, Waxman AB, Mantell L, Du Y, Elias JA,. Interleukin-6 protection in hyperoxic lung injury. Association with diminished apotosis and increased Bcl-2. American Journal of Respiratory and Critical Care Medicine. 1999; 157(4).
  74. Waxman AB, Einarsson O, Seres T, Knickelbein RG, Warshaw JB, Johnston R, Homer RJ, Elias JA. Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. J Clin Invest. 1998 May 1; 101(9):1970-82.
    View in: PubMed
  75. Ward NS, Waxman AB, Einarsson O, Elias JA,. IL-6 protection in hyperoxic lung injury. Plenary Presentation at the Connecticut Thoracic Society Regional Spring Scientific Session, Meriden, CT. 1998.
  76. Waxman AB, Einarsson O, Seres T, Knickelbein RG, Homer R, Warshaw JB, Johnston R, Elias JA,. Elias Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. Plenary Presentation at the Thomas L. Petty Aspen Lung Conference, Aspen Colorado (June 3-6). Chest. 1998; 115.
  77. Waxman AB, Matthay M,. Critical Review of Pulmonary Artery Catheter Use in the ICU. Pulmonary and Critical Care Update. 1998; 12(21).
  78. Siegel M, Waxman AB,. Acute Respiratory Distress Syndrome. Advanced Therapy in Thoracic Surgery (K. Franco and J.B. Putnam, eds). 1998; 1-13.
  79. Waxman AB, Du Y, Elias JA,. Interleukin-11 protection in hyperoxic lung injury. Association with diminished apoptosis and increased Bcl-2. American Journal of Respiratory and Critical Care Medicine. 1998; 157(4).
  80. Waxman AB, White KP, Trawick DR. Electromechanical dissociation following verapamil and propranolol ingestion: a physiologic profile. Cardiology. 1997 Sep-Oct; 88(5):478-81.
    View in: PubMed
  81. Waxman AB, Goldie SJ, Brett-Smith H, Matthay RA. Cytomegalovirus as a primary pulmonary pathogen in AIDS. Chest. 1997 Jan; 111(1):128-34.
    View in: PubMed
  82. Waxman AB, Seres T, Knickelbein RG, Warshaw JB, Elias JA,. IL-11 induced tolerance to 100% oxygen: Role of endogenous antioxidants. American Journal of Respiratory and Critical Care Medicine. 1997; 154(4).
  83. Waxman AB, Ray P, Elias JA. Lung specific inducible expression of interleukin-11 in transgenic mice exhibit enhanced tolerance to 100% oxygen. Chest. 1997; 112(3S):47.
  84. Waxman AB, Matthay RA,. A 51 Year Old woman with a bone marrow transplant and rapidly progressive Dyspnea. Critical Care Pearls. Second Edition, (S.A. Sahn and J.E. Heffner, eds). 1997; 254-256.
  85. Waxman AB, einarsson O, Elias JA, . CC-10-IL-11 Transgenic Mice Exhibit Enhanced Tolerance to 100% Oxygen. Plenary Presentation at the Connecticut Thoracic Society Regional Spring Scientific Session, Meriden CT. 1996.
  86. Waxman AB, Einarsson O, Elias JA,. CC-10-IL-11 transgenic Mice Exhibit Enhanced Tolerance to 100% Oxygen. American Journal of Respiratory and Critical Care Medicine. 1996; 153(4).
  87. Elias JA, Tang WL, Geba GP, Zheng T, Ray P, Wang P, Waxman AB, Einarsson O,. Airway Fibrosis and Enhanced Oxygen Tolerance in IL-11 Overexpression Transgenic Mice. Presented at the 8th International Colloquium on Pulmonary Fibrosis, Oaxaca City, Mexico (11/10-13/1996). 1996.
  88. Waxman AB,. Cytomegalovirus as a Primary Pulmonary Pathogen in AIDS. Plenary presentation at the Connecticut Chapter of the American College of Physicians Regional Spring Scientific Session, Farmington, CT. 1994.
  89. Friedman J, Van Train K, Maddahi J, Rozanski A, Prigent F, Bietendorf J, Waxman A, Berman DS. "Upward creep" of the heart: a frequent source of false-positive reversible defects during thallium-201 stress-redistribution SPECT. J Nucl Med. 1989 Oct; 30(10):1718-22.
    View in: PubMed
  90. Waxman AB, Cooper M, Smith SJ,. Spontaneous intracellular calcium fluctuations occur in neurons of the Embryonic Hippocampus. Society of Neuroscience. 1989; 15.
  91. Smith SJ, Forscher P, Cooper M, Waxman AB,. Developmental events in living neurons and nervious systems. Electron Microscopy Society of America. 1989; 47.
  92. Cooper M, Waxman AB, Banker GA,. Live observation of dynamic events in the formation of cerebral cortex by laser microscopy. Society of Neuroscience . 1989; 15.
  93. Connelly J, Waxman AB, Klemm WR,. The Pig Brain in Stereotaxic Coordinates. 1989.
  94. Smith SJ, Cooper MW, Waxman AB,. Laser Microscopy of Subcellular Structure in Living Neocortex: Can One See Dendritic Spices Twitch?. Proceedings of 23rd Symposium Medicum Hoechst on "The Biology of Memory", Eds. L. Squire and E. Lindenlaub. 1989; 237-256.
  95. Higgins D, Waxman A, Banker G. The distribution of microtubule-associated protein 2 changes when dendritic growth is induced in rat sympathetic neurons in vitro. Neuroscience. 1988 Feb; 24(2):583-92.
    View in: PubMed
  96. Banker GA, Waxman AB, Klemm WR,. Hippocampal neurons generate natural shapes in cell culture. Intrinsic Determinants of Neuronal Form. (R. Lasek and M.B. Black, eds.). 1988; 128-140.
  97. Waxman AB,. The Role of Cell Interactions in the Development of Dendritic Arbors of Hippocampal Neurons in Culture. Doctoral Thesis. 1988.
  98. Waxman AB, Banker GA,. An analysis of the role of cell contact in the development of dendritic. Society for Neuroscience. 1987; 13.
  99. Mohsenifar Z, Ross MD, Waxman A, Goldbach P, Koerner SK. Changes in distribution of lung perfusion and ventilation at rest and during maximal exercise. Chest. 1985 Mar; 87(3):359-62.
    View in: PubMed
  100. Waxman AB, Banker GA,. An analysis of the dentritic form of hippocampal neurons in dissociated-cell culture grown at different densities. Society for Neuroscience. 1985; 11.
  101. Waxman AB, Banker GA,. An analysis of the dendritic form of hippocampal neurons in dissociated-cell culture. The Anatomical Record. 1985; 211(No 3).
  102. Gutman J, Brachman M, Rozanski A, Maddahi J, Waxman A, Berman DS. Enhanced detection of proximal right coronary artery stenosis with the additional analysis of right ventricular thallium-201 uptake in stress scintigrams. Am J Cardiol. 1983 May 1; 51(8):1256-60.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Waxman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_